Current Issue October 2023
The benefits of choosing private healthcare in 2023
Being able to access high-quality healthcare at the times you need it most is vital. Regardless of whether this is a simple check-up, a...
Rewarding business ideas for developing a career in mental health
Following centuries of stigma, the importance of mental wellness is finally matching that of physical healthcare.
Conditions such as depression have become common topics in...
Kelso Pharma launches its first product ‘Acepiro’
Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market...
Addiction Drug Showing Signs Of Promise For Treating Long Covid Symptoms
The number of people suffering from addiction is at an all time high, with more people seeking treatment across the USA due to the...
Reasons to Consider a Locum Tenens Position
Doctors are highly driven professionals seeking exceptional care and service for their clients. Some doctors may have private practices, while others serve in different...
Community pharmacy at high risk of burnout, reveals RPS Workforce Wellbeing survey
Ninety-six per cent of community pharmacists surveyed in the Royal Pharmaceutical Society (RPS) Workforce Wellbeing survey said they were at 'risk of burnout'.
A higher...
How To Approach An Addicted Partner To Get Help: Top Tips
We love our partners, and it’s likely that we’d do anything for them. We put up with their foibles and we bite our tongue...
Best-Practice Methods When Dealing with a Hectic Schedule
One of the most challenging aspects of living a healthier lifestyle is trying to accomplish your goals while simultaneously dealing with a hectic schedule....
AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
Pharmaceutical giant AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday (November 29) as it seeks...
Rare success for Alzheimer’s research unlocks hope for future therapies
The first big breakthrough in 30 years of Alzheimer ’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark...